Helene Thygessen

The Netherlands Cancer Institute

Papers

1

Total Citations

61

H-Index

1

About

Helene Thygessen is a pioneering researcher at the intersection of nuclear medicine and surgical innovation, with a primary focus on sentinel node mapping and multimodal imaging for cancer staging. Her landmark 2016 work on multimodal hybrid imaging agents for sentinel node mapping represents a critical contribution to the field, earning 61 citations for its visionary approach to reconnecting nuclear medicine with advances in robot-assisted surgery. Thygessen's research addresses a pressing clinical challenge: the need for precise, real-time visualization of sentinel lymph nodes during minimally invasive procedures like radical prostatectomy and extended pelvic lymph node dissection. By developing hybrid imaging agents that combine radioactive and fluorescent properties, she has enabled surgeons to seamlessly integrate preoperative nuclear imaging with intraoperative robotic guidance, improving the accuracy of lymph node staging in prostate cancer patients. Her work bridges the gap between traditional nuclear medicine techniques and cutting-edge surgical robotics, offering a pathway to more targeted, less invasive cancer treatments. Thygessen's contributions are particularly notable for their translational impact, directly influencing how surgeons identify and remove sentinel and non-sentinel lymph nodes at risk of containing metastases.

Research Focus

Key Achievements

1
H-Index
1
Papers
61
Total Citations
61
Avg Citations/Paper
🏆 Most Cited Paper
Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery
61 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago